Emerging and emerged pathogenic Candida species: beyond the Candida albicans paradigm
- PMID: 24086128
- PMCID: PMC3784480
- DOI: 10.1371/journal.ppat.1003550
Emerging and emerged pathogenic Candida species: beyond the Candida albicans paradigm
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- Pfaller MA, Diekema DJ (2007) Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 20: 133–163 doi:10.1128/CMR.00029-06 - DOI - PMC - PubMed
-
- Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Ellis D, et al. (2010) Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion. J Clin Microbiol 48: 1366–1377 doi:10.1128/JCM.02117-09 - DOI - PMC - PubMed
-
- Krcmery V, Barnes AJ (2002) Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. J Hosp Infect 50: 243–260 doi:10.1053/jhin.2001.1151 - DOI - PubMed
-
- Walker LA, Gow NA, Munro CA (2013) Elevated chitin content reduces the susceptibility of Candida species to caspofungin. Antimicrob Agents Chemother 57: 146–154 doi:10.1128/AAC.01486-12 - DOI - PMC - PubMed
-
- Papon N, Courdavault V, Clastre M, Simkin AJ, Crèche J, et al. (2012) Deus ex Candida genetics: overcoming the hurdles for the development of a molecular toolbox in the CTG clade. Microbiology 158: 585–600 doi:10.1099/mic.0.055244-0 - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
